HOME LOGISTICS MARKETING/BI ABOUT US PRESS JOBS FOLLOW US Your browser does not support the video tag. Europe's most advanced Digital Pharmacy Best in class logistics in europe Fully automated warehouse Highest delivery quality Digital marketing excellence One of the fastest growing online pharmacies eRx as a strategic cornerstone for Apologistics Extreme fairly priced products Continuously developing new markets and improving our business Strategic Location in the Netherlands Our facilities in the netherlands and in germany NL, most liberal pharmaceutical law in EU Investments in NL pharmacies B.V. possible Internationalization out of the Netherlands NL location at border to the densest area in Germany and our biggest customer base Close proximity to the biggest and latest DHL hub Same day delivery to 20 M inhabitants in Germany in progress Fully automated online pharmacy in the Netherlands One of the first robot bin picking warehouses, worldwide Capacity beyond € 1.5 B in 3 phases Soccer field size, state of the art warehousing Best in class IT and logistic workflow to operate at highest possible profitability Highly scalable concept 24/7 output of more than 5500 parcels per hour Minimal number of only 20 logistics employees per shift required Fulfillment: Fully automated 24/7 robot picking out of bins Automation level > 90% Modular Infrastructure Highly scalable and duplicable in less than 9 months Quality-check: 100% control of all outgoing packages scanned by picking robots and rescanned by pharmacists Shipping: seamless tracking, barcode monitoring and email confirmation to our customers by Apologistics & DHL Delivery: same day delivery via DHL Express to more than 20 M inhabitants in Germany Fleet of Apologistics trucks with built in cargo floors, unloading in less than 3 minutes Automated Guided Vehicles (AGVs) for moving pallets, bins and cleaning DHL truck loaded through automation Innovation: constant optimisation Digital Pharmacy Marketing & Business Intelligence Data driven business intelligence M&A activities: 5 successful integrations of 5 competitors between 2015-2018 Brand building and consolidation with focus on apo-discounter.de Data driven SEO/SEA & social meda campaigns for efficient customer acquisition apo-discounter.de is the award winning leading online pharmacy in social media Extensive A/B tests & web analysis Dynamic pricing with AI Personalisation and reactivation engine for different customer groups Platform for mapping entire customer journey in progress Futuristic working space Offices with High-Tech-Equipment Apologistics goes green Goal: become CO2 neutral Sustainability is a key company goal for Apologistics Goal: to become CO2 neutral Electric and hybrid company cars LEDs in the entire facility Solar-Panels in preparation State of the art trash sorting and handling Bio-degradable packaging / filling material Who we are Dr. Oliver Scheel CEO Dirk Wappler CEO & CO-FOUNDER Andrea Skersies CMO Nico Grunert CFO Mario Brosche HEAD OF LEGAL Ulrike Rentsch ASSISTANT MANAGER Daniel Bauer HEAD OF HR Anke Kirchner HEAD OF CUSTOMER SERVICE Robert Kudrass HEAD OF REGULATORY AFFAIRS Friedrich Lorek HEAD OF AUTOMATION AND TECHNOLOGY Carsten Werner HEAD OF PRODUCTION Christian Richter MANAGER MARKETING Maik Kirsten HEAD OF MEDIA OPERATIONS Christian Klossek HEAD OF IT Daniel Mühl COO (DUIVEN) Ingrid Degen HR/OM (DUIVEN) Dr. Jeffrey Kupka PHARMACIST (DUIVEN) Our Brands Pharmaceutical market overview Germany "Germany: highly attractive and rapidly changing healthcare market" "eRx game changer for the industry" - We want to play a dominant role in this. "Huge potential, just a small portion of Rx market shifted to online" - € 5 B shift from offline to online exprected "The e-prescription will accelerate stationary pharmacy consolidation and ensure high online Rx growth." "The issuing of follow-up prescriptions by pharmacists is highly advantage for online pharmacies" "Half of consumers can imagine redeeming an e-prescription online" "Manufacturers have the most positive attitude towards the introdution of the e-prescription" "Clear winners of e-prescriptions will be online pharmacies" Source: Dr.Kaske, eRx Study 2019 Dr.Kaske specialized as a full-service marketing agency for manufacturers, market research and pharmacies Der Online - Apothekenmarkt in Deutschland wird sich bis 2025 verfünffachen (EUR Milliarden) 72.4% 13.0% 11.9% CAGR 2020 - 2025 0,6 0,9 3,8 9,0 0,9 1,0 1,3 1,7 0,9 1,0 1,3 1,6 2,9 2,4 12,3 6,4 38% Online CHC (excl. OTC) Online OTC Online Rx Einführung E - Rezept ab Januar 2022 Our Partners Our Investors THI Investments is a single family office founded in January 2016 after divesting an 80 year-old family business. Our goal is to invest in a diversified portfolio of financial and company assets and grow them over the long term. We are entrepreneurs, industrialists and investors. Our companies are designed to adapt to and thrive on rapid global changes, such as digitisation, demographics, urbanisation and resource sustainability. Success is defined not only by the returns and growth we achieve – but also by how we achieve them. THI Investments is values-driven because that’s the way its owners, management and team want it to be. Our partners’, co-investors’ and team members’ success is part of how we measure our performance. We manage risk through diversification, flexibility, execution excellence, partnership and a positive and optimistic outlook. We have the patience and the vision to realise success over the long term. Our business partners Press Release DR OLIVER SCHEEL NEW CEO AT APOLOGISTICS GMBH Leipzig, April 2021 On 1 April 2021, Dr Oliver Scheel took over as CEO of the Apologistics Group from founder and long-time CEO Michael Fritsch, who built up the company and led it to its current success. With overall responsibility, Dr Scheel will lead the further growth of the Apologistics Group and further expand its position as the largest privately owned "pharmacy for all" in the German healthcare market. Michael Fritsch will remain on the company's advisory board and will continue to support the successful growth of the company with his extensive expertise in the pharmacy market as an advisor and shareholder. ...read more Download PDF Press release INTERVIEW WITH HANDELSBLATT Düsseldorf, Frankfurt, 30 November 2020 Deutsche Digitalapotheke nimmt es mit den ausländischen Branchenprimi auf Als Betreiber der drittgrößten Versandapotheke in Deutschland hat Michael Fritsch ehrgeizige Ziele – und fürchtet weder die direkte Konkurrenz noch Amazon. read complete interview on www.handelsblatt.com APOLOGISTICS ANNOUNCES PARTNERSHIP WITH THI INVESTMENTS Leipzig, 27 March 2018 Apologistics GmbH, a Leipzig-based logistics service provider for online pharmacies, announced a strategic partnership with THI Investments GmbH: Founded in 2004, Apologistics is located close to DHL’s European logistics hub in Leipzig and operates an industry-leading, fully-automated logistics service centre for OTC (non-prescription) drugs and beauty & care products which can handle up to 8 million parcels per year. ...read more Download PDF Press release IMPRINT | PRIVACY POLICY © 2004 – 2021 apologistics GmbH; Logos, Produkt- und Markenzeichen sind Eigentum ihrer jeweiligen Besitzer. Imprint Apologistics GmbH Magdeborner Str. 14 04416 Markkleeberg Germany Standort Duiven Express 2 6921 RB Duiven, Niederlande Tel: +49 341 56681079 Fax: +49 341 56681078 E-Mail: kontakt@apologistics.com Geschäftsleitung Dr. Oliver Scheel, Dirk Wappler Sitz: Markkleeberg Registergericht: Leipzig HRB 23075 USt-Id-Nr.: DE253393827 Verantwortlicher im Sinne des Presserechts Robert Kudrass Tel: +49 341 56681079 E-Mail: r.kudrass@apologistics-gmbh.de Zuständige Aufsichtsbehörde gemäß §5 Abs. (1) Nr. 3 TMG Landesdirektion Sachsen Dienststelle Dresden Referat 24 L, Pharmazie, GMP-Inspektorat Stauffenbergallee 2 01099 Dresden Alle Bildrechte liegen bei Apologistics GmbH (ggf. Einzelbildnachweise). Privacy policy of Apologistics GmbH 1 Information on the collection of personal data (1) In the following we inform you about the collection of personal data which we collect from you when you contact us by e-mail or telephone or when you visit our website. Personal data are all information relating to an identified or identifiable natural person, e.g. name, address, date of birth. (2) The responsible person pursuant to Art. 4 Para. 7 EU General Data Protection Regulation (GDPR) is Apologistics GmbH, Apelsteinallee 13, 04416 Markkleeberg, represented by Dr Oliver Scheel and Dirk Wappler. You can reach our data protection officer by e-mail: r.kudrass@apologistics-gmbh.de or by post with the addition "the data protection officer". 2 Your rights (1) You have the following rights regarding your personal data: Right of access Right of rectification or erasure Right to restriction of processing Right to object to processing Right to data portability. (2) You also have the right to complain to a data protection supervisory authority about the processing of your personal data by us. 3 Contact by e-mail or telephone When you contact us by e-mail or telephone, the data you provide us with (your e-mail address, possibly your name or telephone number) will be stored by us in order to answer your questions. We will delete the data collected in this context once storaging is no longer necessary or we will restrict processing if there are legal archiving obligations. The legal basis for this is Art. 6 Para. 1 S. 1 lit. b GDPR. 4 Collection of personal data when visiting our website (1) If you only use our website for information purposes, i.e. if you do not provide us with any other information, we only collect the personal data that your browser transmits to our server. If you wish to view our website only, we collect the following data, which is technically necessary for us to display our website to you and to ensure stability and security (legal basis is Art. 6 Para. 1 S. 1 lit. f GDPR): IP address Date and time of the request Time zone difference to Greenwich Mean Time (GMT) Contents of the request (concrete page) Access status/HTTP status code amount of data transferred in each case Website from which the request originates browser Operating system and its interface Language and version of the browser software. (2) If the storage of your data is no more required, we will delete it or restrict the processing if there are legal archiving obligations. (3) We do not use any cookies or other tracking tools for our website. 5 Revocation or objection to the processing of your data (1) If you have given your consent to the processing of your data, you can revoke it at any time. Such a revocation is effective for the future and does not affect the legality of the data processed until the revocation. (2) Insofar as we based the processing of your personal data on our legitimate interests, you may object to the processing of your data. In the event of such an objection, we ask you to explain the reasons why we should not process your personal data as we have done. In the event of your justified objection, we will examine the situation and either discontinue or adapt the data processing or point out our compelling reasons worthy of protection on the basis of which we will continue the processing. 6 Subject to change We reserve the right of changing this privacy policy at any time in accordance with legal requirements (in particular for the purpose of adaptation due to changes in the law or the inclusion of new service providers). All changes will be published on our website, so that you can always inform yourself about our current data protection information.